UTAH MEDICAL PRODUCTS, INC. Inventory, Raw Materials, Gross
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Inventory, Raw Materials, Gross of $5.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Inventory
us-gaap:InventoryRawMaterials · last filed 2026-08-12
- 2026-06-30: Inventory, Raw Materials, Gross $5.50M.
- 2026-03-31: Inventory, Raw Materials, Gross $5.31M.
- 2025-12-31: Inventory, Raw Materials, Gross $5.08M.
- 2025-09-30: Inventory, Raw Materials, Gross $5.29M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $5.50M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $5.31M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $5.08M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $5.29M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.86M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.50M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.49M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $6.31M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.29M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.30M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $6.39M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $5.72M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $6.17M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $6.50M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $5.72M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $5.34M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.43M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $4.03M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $3.73M 10-K/A · filed 2023-03-28 | |
| 2021-09-30 | $3.40M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.77M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $3.44M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $3.48M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $3.47M 10-Q/A · filed 2020-11-09 | |
| 2020-06-30 | $4.08M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.08M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $4.18M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.47M 10-Q · filed 2020-11-06 | $3.35M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.35M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.83M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.18M 10-Q · filed 2020-11-06 | $2.69M 10-K · filed 2019-03-14 |
| 2018-09-30 | $2.40M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.58M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.71M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.66M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $2.48M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.38M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $2.44M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $2.27M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $2.13M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.85M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $2.07M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $1.52M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $1.81M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.82M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.89M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $1.92M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $2.24M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $2.33M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $2.41M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $2.23M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $2.25M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $1.85M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.87M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.78M 10-K · filed 2014-03-12 | |
| 2012-09-30 | $1.94M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.81M 10-Q · filed 2012-08-08 | |
| 2011-12-31 | $1.69M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |